Fineline Cube

Follow:
14409 Articles
Saizeng Medical Licenses TSHR Antibody to Yarrow for $1.4B in Graves' Disease Deal
CompanyDeals

Saizeng Medical Licenses TSHR Antibody to Yarrow for $1.4B in Graves’ Disease Deal

Zhicheng's TAVR Robotic System Enters NMPA Innovation Pathway
CompanyMedical Device

Zhicheng’s TAVR Robotic System Enters NMPA Innovation Pathway

ENHERTU Wins FDA Approval as First-Line HER2 Breast Cancer Therapy
CompanyDrug

ENHERTU Wins FDA Approval as First-Line HER2 Breast Cancer Therapy

FDA Removes Key RWE Limitation, Allowing Drug and Device Submissions Without Individual Patient Data
Policy / Regulatory

FDA Removes Key RWE Limitation, Allowing Drug and Device Submissions Without Individual Patient Data

Sanofi’s Tolebrutinib Fails Phase 3 PPMS Endpoint, Halting Registration Plans
CompanyDrug

Sanofi’s Tolebrutinib Fails Phase 3 PPMS Endpoint, Halting Registration Plans

Konruns Doses First Patient in Phase 2 Esophageal Cancer Trial for KC1036
CompanyDrug

Konruns Doses First Patient in Phase 2 Esophageal Cancer Trial for KC1036

Johnson & Johnson's TECVAYLI Gets FDA Priority Review for Myeloma Combo
CompanyDrug

Johnson & Johnson’s TECVAYLI Gets FDA Priority Review for Myeloma Combo

uBriGene Partners with Circurna on circRNA Manufacturing for Global Trials
CompanyDeals

uBriGene Partners with Circurna on circRNA Manufacturing for Global Trials

Dren Bio, Sanofi Forge $1.8B B‑Cell Therapy Deal with US Co‑Promote Option
CompanyDeals

Dren Bio, Sanofi Forge $1.8B B‑Cell Therapy Deal with US Co‑Promote Option

Adaptive Licenses TCR Data to Pfizer in $890M Deal for Rheumatoid Arthritis
CompanyDeals

Adaptive Licenses TCR Data to Pfizer in $890M Deal for Rheumatoid Arthritis

Hengrui NMPA Approves Four Clinical Trials Advancing Oncology and Metabolic Pipeline
CompanyDrug

Hengrui NMPA Approves Four Clinical Trials Advancing Oncology and Metabolic Pipeline

GSK's Nucala Wins CHMP Nod for COPD in Europe
CompanyDrug

GSK’s Nucala Wins CHMP Nod for COPD in Europe